CHANEX

Oxford Biomedica Plc

Application Filed: 2007-02-27

Trademark Application Details

Mark For: CHANEX® trademark registration is intended to cover the categories of clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapuetic compositions containing nucleic acids for gene therapy; pharmaceutical preparations containing nucleic acid for use in the treatment of cancer, hiv and aids-related infections and bodily conditions associated with impaired immunosystems, viral and bactierial diseases, cancer and cystic fibrosis; pharmaceutical preparations in the field of gene therapy; pharmacuetical preparations for the treatment of cystic fibrosis.

Status

2021-07-25 UTC

DEAD REGISTRATION Cancelled Invalidated

The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.

Research	OneLook Acronym Finder
Serial Number	77116990
Registration Number	3408109
Mark Literal Elements	CHANEX
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	Trademark, Service Mark
Current Location	PUBLICATION AND ISSUE SECTION 2008-04-08
Basis	44(e)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	No
Filed ITU	No
44D Filed	No
44E Current	Yes
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Domestic Representative	Howard N. Aronson
Attorney Name	Howard N. Aronson
Attorney Docket Number	10616
Law Office Assigned	M20
Employee Name	LEHKER, DAWN FELDMAN

Timeline

2007-02-27	Application Filed
2008-01-22	Published
2008-01-22	Published for Opposition
2008-04-08	Location: PUBLICATION AND ISSUE SECTION
2008-04-08	Trademark Registered
2014-11-14	Cancelled
2014-11-14	Status: Dead/Cancelled
2014-11-14	Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	OXFORD BIOMEDICA PLC
Address	THE OXFORD SCIENCE PARK MEDAWAR CENTRE, ROBERT ROBINSON AVENUE OXFORD UNITED KINGDOM OX44GA
Legal Entity Type	Company
Legal Entity State	UNITED KINGDOM

Documents

Application	MULTI	2007-02-27
Drawing	JPEG	2007-02-27
Offc Action Outgoing	XML	2007-05-11
XSearch Search Summary	XML	2007-05-11
Paper Correspondence Incoming	TIFF	2007-11-05
Amendment and Mail Process Complete	MULTI	2007-12-14
Publication & Issue Review Complete	MULTI	2007-12-18
TRAM Snapshot of App at Pub for Oppostn	MULTI	2007-12-18
Notice of Publication	XML	2008-01-02
Registration Certificate	TIFF	2008-04-08

Attorney of Record

HOWARD N. ARONSON
LACKENBACH SIEGEL LLP
1 CHASE RD
SCARSDALE, NY 10583-4156

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	10
U.S. Codes:	026,039,044
International Codes:	42
U.S. Codes:	100,101

Type Code	Type
GS0051	CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPUETIC COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACID FOR USE IN THE TREATMENT OF CANCER, HIV AND AIDS-RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS, VIRAL AND BACTIERIAL DISEASES, CANCER AND CYSTIC FIBROSIS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACUETICAL PREPARATIONS FOR THE TREATMENT OF CYSTIC FIBROSIS

Type Code

Type

GS0051

CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPUETIC COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACID FOR USE IN THE TREATMENT OF CANCER, HIV AND AIDS-RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS, VIRAL AND BACTIERIAL DISEASES, CANCER AND CYSTIC FIBROSIS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACUETICAL PREPARATIONS FOR THE TREATMENT OF CYSTIC FIBROSIS

Trademark Filing History

Description	Date	Proceeding Number
CANCELLED SEC. 8 (6-YR)	2014-11-14
REGISTERED-PRINCIPAL REGISTER	2008-04-08
PUBLISHED FOR OPPOSITION	2008-01-22
NOTICE OF PUBLICATION	2008-01-02
LAW OFFICE PUBLICATION REVIEW COMPLETED	2007-12-17	78289
APPROVED FOR PUB - PRINCIPAL REGISTER	2007-12-17
CORRESPONDENCE RECEIVED IN LAW OFFICE	2007-12-13	78289
ASSIGNED TO LIE	2007-12-13	78289
AMENDMENT FROM APPLICANT ENTERED	2007-12-13	78289
PAPER RECEIVED	2007-11-05
NON-FINAL ACTION WRITTEN	2007-05-11	74662
NON-FINAL ACTION E-MAILED	2007-05-11	6325
ASSIGNED TO EXAMINER	2007-05-09	74662
NEW APPLICATION ENTERED IN TRAM	2007-03-02

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
CHANEX 88556760 not registered Live/Pending	Tinka (Shanghai) Trading Co., Ltd 2019-08-01
CHANEX 77116990 3408109 Dead/Cancelled	OXFORD BIOMEDICA PLC 2007-02-27
CHANEX 75559264 2437902 Dead/Cancelled	Oxford BioMedica plc 1998-09-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.